Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Friday, April 19, 2024 | Back issues
Courthouse News Service Courthouse News Service

Prescription Drug

BOSTON - Insurers claim in an antitrust class action that Astellas Pharma gouged prices and illegally blocked entry of generic Prograf (tacrolimus), used to suppress organ rejection in transplants.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...